Institutional Only|Drovix does not deal with individual investors and does not accept deposits or provide retail trading services.

Drovix.
Financial insights and market analysis editorial workspace
Education

From RFP to First Fill: A 6-Week Liquidity Onboarding Playbook

Day-by-day project plan for onboarding a wholesale liquidity provider in six weeks — KYC, contracting, FIX certification, parallel running, throttled cutover, and the 90-day review.

HomeResourcesInsights & News
25 May 2026Drovix Research Desk10 min

This is the project plan we hand to new counterparties at Drovix on day one. It is the same plan we use whether the buyer is a 50-person retail broker in Cyprus or a multi-billion-dollar hedge fund in London — the surface area changes, the structure does not.

Six weeks is the realistic baseline. Faster is possible, but every week you shave off compounds operational risk; the cost of a botched go-live is almost always higher than the cost of two more weeks of preparation.

Week 0 — RFP and shortlisting

Before day one of the six weeks, you have already shortlisted to no more than three providers and chosen one. The RFP should follow the twelve questions in our buyer's guide. Do not start the clock until you have a signed term sheet with your preferred counterparty and a fall-back option warm.

Week 1 — KYC and documentation

Day 1–2: Send the full KYC pack. Use a checklist; missing documents are the #1 cause of week-one delay.

Day 3–5: Provider compliance review. Expect at least one round of follow-up questions; respond within 24 hours.

Day 5: Receive provisional credit limits and the platform fee quote.

KYC documents checklist

  • Certificate of incorporation
  • UBO chart with all owners ≥10%, certified within last six months
  • Audited financials, last two years
  • Regulatory licence(s) — original PDF, not screenshot
  • AML/CFT policy and board approval
  • Directors' and UBOs' certified passports + proof of address ≤3 months old
  • Bank reference letter for the account that will wire collateral

Week 2 — Contracting and credit

Day 6–8: Legal review of master agreement and CSA equivalent. Most pushback is around governing law and termination triggers; keep the legal team focused on the few clauses that actually matter (default, close-out netting, dispute jurisdiction).

Day 9–10: Wire test collateral (typically USD 100k for setup, scaled up later). Confirm bank rails work both directions.

Day 10: Sign master agreement, receive UAT credentials.

Week 3 — FIX certification, part one

Day 11: UAT logon, verify session parameters (heartbeat, sequence numbers, encryption).

Day 12–13: Order entry tests — new order single, replace, cancel, partial fills, market data subscription.

Day 14–15: Symbol mapping certification for every instrument you plan to trade. Do not skip this step. Run a script that walks every symbol on both sides and reconciles the metadata.

Week 4 — FIX certification, part two

Day 16–17: Burst testing at 10x normal message rate. Confirm throttling behaviour matches the FIX spec your engine expects.

Day 18–19: Failover drill — kill primary venue mid-trade, verify automatic re-routing.

Day 19: Drop-copy reconciliation against your back-office, end-to-end, for at least 100 simulated tickets.

Day 20: Sign-off from both technical teams; provisional production credentials issued.

Week 5 — Parallel running

Day 21: Connect production FIX session in parallel mode — shadow only, no execution.

Day 22–25: Record live quote stream alongside incumbent. Compute matched-cohort effective spread and last-look statistics daily.

Day 25: Internal review meeting. Decide whether to proceed; if not, extend parallel for another week.

Week 6 — Throttled cutover and first fills

Day 26: Enable execution at 10% routing share for the chosen first asset class (usually metals or exotics where you have headroom — not EUR/USD).

Day 27: First live fills. Compare against parallel-period predictions. Investigate any variance ≥10 bps.

Day 28: Increase to 25%. Hold for 24 hours of full session coverage.

Day 29: Increase to 50% if execution metrics are within tolerance.

Day 30: 100% on the first asset class. Begin parallel for the second asset class.

Post go-live — the 90-day review

At day 30, 60, and 90 from first live fill, hold a formal review covering fill ratio, effective spread, last-look statistics, latency percentiles, and post-trade reconciliation break rate. The 90-day review is the one where you decide whether the provider is delivering against the RFP commitments. Anything material that has drifted needs a remediation plan in writing.

The Drovix onboarding cadence

Drovix runs this playbook with a single named project manager from day one to day 90, including a shared project tracker so both sides see the same status at the same time. We default to symmetric last-look, publish capacity curves before you sign, and provide the parallel-run shadow session at no incremental cost.

If you want to see the project tracker template (we are happy to give it to non-customers as well — better playbooks raise the floor for everyone), the institutional sales desk will send it on request.

Analyst Desk

Drovix Research Desk

Institutional Research

Drovix Research Desk publishes institutional-grade analysis covering macro events, cross-asset correlations, and execution insights for professional market participants.

Frequently Asked Questions

Q1.Can onboarding be compressed below six weeks?+
Technically yes, in three to four weeks if both sides prioritise. Practically no — credit and KYC review are gated by humans on both sides, and FIX certification needs at least one full week to cover burst behaviour and failover. Compressing tends to push problems into production.
Q2.What documents are needed for KYC?+
Company registration, ownership chart down to ultimate beneficial owners holding ≥10%, audited financials for the last two years (or a board-approved management account if newer), regulatory licence(s), AML policy, and certified IDs/passports for directors and UBOs.
Q3.What goes wrong most often?+
Symbol mapping. Almost every broker has slightly non-standard tickers for index CFDs, metals, or exotic FX. Skipping the symbol mapping certification step is the single most common cause of a production incident in the first week.

Related Reads

Education

The True Cost of Institutional Liquidity: Beyond the Quoted Spread

Next Read

Education

Switching Liquidity Providers Without Breaking Execution Quality

Next Read

Education

Drovix Liquidity for Regulated Brokers: A 2026 Buyer's Guide

Next Read

Back to Insights
Drovix.

Institutional-grade liquidity, connectivity, and analytics for professional market participants worldwide.

About

  • Why Drovix
  • About Us
  • Regulation
  • Technology
  • Contact
  • Insights
  • Execution Policy

Legal

  • Privacy
  • Terms and Agreements
  • Client Agreement
  • Regulatory Status
  • Risk Disclosure

Policies

  • AML/KYC Policy
  • Cookie Policy
  • Order Execution Policy
  • Complaints Handling
  • Reverse Solicitation
  • Site map

Risk Warning: Trading leveraged products such as Forex and CFDs carries a significant level of risk and may not be appropriate for all market participants. The value of derivative instruments can fluctuate rapidly, and losses may exceed initial margin. Institutional and professional clients should ensure they fully understand the risks associated with leveraged products before engaging in any transactions. Past performance is not indicative of future results. A significant proportion of professional client accounts incur losses when trading leveraged products. Prospective clients should ensure they have sufficient expertise and resources to bear the risks of leveraged trading. You should not commit capital that you cannot afford to lose.

Important — No Investor Compensation: Important: Client funds held with Drovix (MU) Ltd are not protected by any government deposit guarantee or investor compensation scheme. The Financial Services Commission (FSC) of Mauritius does not operate an investor compensation fund.

The information on this website is intended for institutional and professional clients only. It does not constitute investment advice, a solicitation, or a recommendation to enter into any transaction. Drovix does not provide services to retail clients.

Reverse Solicitation Notice: The information and services on this website are not directed at or intended for distribution to residents or nationals of any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Institutional clients access Drovix (MU) Ltd services on their own initiative. It is the responsibility of each prospective institutional client to ensure compliance with the laws and regulations of their jurisdiction of incorporation or domicile.

This information is not intended for entities or persons in countries or jurisdictions under significant sanctions, including but not limited to Afghanistan, Barbados, Belarus, Burkina Faso, Cameroon, Central African Republic, Cuba, Democratic Republic of Congo, Haiti, Iran, Libya, Mali, Mozambique, Myanmar, Nicaragua, North Korea, Russia, Senegal, Sudan, Syria, Tanzania, Venezuela, Yemen, and Zimbabwe.

All information, products, and services offered on the Drovix website are not intended for entities or persons in Australia, Belgium, Canada, France, Japan, Malaysia, Poland, Ukraine, the United Kingdom, or the United States. The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. Drovix services are available exclusively to eligible institutional and professional clients.

© 2026 Drovix (MU) Ltd. All rights reserved.

Drovix (MU) Ltd is authorised and regulated by the Financial Services Commission (FSC) of Mauritius as an Investment Dealer (Full Service Dealer) under licence number GB21026813.

Drovix (MU) Ltd is not authorised by the United Kingdom Financial Conduct Authority and is not registered with the U.S. SEC, CFTC or NFA. Nothing on this website constitutes a financial promotion under section 21 of the UK Financial Services and Markets Act 2000.

The company operates under www.drovix.com and is registered at C/o SALVUS (Mauritius) Ltd, Silver Bank Tower, Ground Floor, 18 Bank Street, Cybercity, Ebene 72201 Mauritius.